EmblemHealth is pleased to announce the addition of Dr. Scott Breidbart, MD, MBA, as Chief Clinical Officer. Reporting directly to Karen Ignagni, President and CEO, Dr. Breidbart will be an integral member of the senior leadership team as EmblemHealth works to lead the region in quality-based payment models.
“Scott has a distinguished record of performance. He has pioneered innovative partnerships between health plans and clinicians, developed model quality assurance programs and has been a leader in moving the delivery system from a volume-based to a value-based focus,” said Ms. Ignagni.
Dr. Breidbart will be responsible for medical and clinical policy, quality assurance, pharmacy and medical management. “EmblemHealth has a long and storied history of making the health and wellness of New Yorkers its top priority,” said Dr. Breidbart. “I am honored to join the company and to be part of this rich legacy of serving its members and the entire New York community. I look forward to working with Karen and all of Emblem’s leadership team.”
To learn more, read the press release,
EmblemHealth Appoints Dr. Scott Breidbart Chief Clinical Officer.